FLANAX NOCTO

This brand name is authorized in Mexico.

Active ingredients

The drug FLANAX NOCTO contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Naproxen UNII `57Y76R9ATQ` - NAPROXEN
	Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis.
	Read more about Naproxen
`2`	Diphenhydramine UNII `8GTS82S83M` - DIPHENHYDRAMINE
	Diphenhydramine is an ethanolamine-derivative antihistamine. It is an antihistamine with anticholinergic and marked sedative effects. It acts by inhibiting the effects on H₁-receptors. Diphenhydramine is effective in reducing sleep onset (i.e., time to fall asleep) and increasing the depth and quality of sleep.
	Read more about Diphenhydramine

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	271M2016

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.